138 related articles for article (PubMed ID: 28450104)
1. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
[TBL] [Abstract][Full Text] [Related]
2. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
3. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
Classen JF; Henrohn D; Rorsman F; Lennartsson J; Lauwerys BR; Wikström G; Rorsman C; Lenglez S; Franck-Larsson K; Tomasi JP; Kämpe O; Vanthuyne M; Houssiau FA; Demoulin JB
Arthritis Rheum; 2009 Apr; 60(4):1137-44. PubMed ID: 19333949
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus.
Kurasawa K; Arai S; Owada T; Maezawa R; Kumano K; Fukuda T
Mod Rheumatol; 2010 Oct; 20(5):458-65. PubMed ID: 20490598
[TBL] [Abstract][Full Text] [Related]
6. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.
Balada E; Simeón-Aznar CP; Ordi-Ros J; Rosa-Leyva M; Selva-O'Callaghan A; Pardos-Gea J; Fonollosa-Pla V; Vilardell-Tarrés M
Ann Rheum Dis; 2008 Jul; 67(7):1027-9. PubMed ID: 18272670
[TBL] [Abstract][Full Text] [Related]
7. Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.
Moroncini G; Svegliati S; Grieco A; Cuccioloni M; Mozzicafreddo M; Paolini C; Agarbati S; Spadoni T; Amoresano A; Pinto G; Chen Q; Benfaremo D; Tonnini C; Senzacqua M; Alizzi S; Nieto K; Finke D; Viola N; Amico D; Galgani M; Gasparini S; Zuccatosta L; Menzo S; Müller M; Kleinschmidt J; Funaro A; Giordano A; La Cava A; Dorfmüller P; Amoroso A; Pucci P; Pezone A; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2024 Apr; 76(4):620-630. PubMed ID: 37975161
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
Front Immunol; 2018; 9():428. PubMed ID: 29623076
[TBL] [Abstract][Full Text] [Related]
9. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
10. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
[TBL] [Abstract][Full Text] [Related]
13. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
19. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
